Private Advisor Group’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-42,408
Closed -$1.21M 2837
2026
Q1
$1.21M Buy
42,408
+922
+2% +$26.9K 0.01% 1305
2025
Q4
$1.17M Buy
41,486
+25,443
+159% +$718K 0.01% 1318
2025
Q3
$448K Buy
+16,043
New +$437K ﹤0.01% 1829

Other funds holding REVS

Private Advisor Group's REVS Position: Q2 2026 in Review

Private Advisor Group sold out of Columbia Research Enhanced Value ETF (REVS) in Q2 2026, closing a stake of 42,408 shares — an estimated $1.21M sold.

Private Advisor Group first reported a position in REVS in Q3 2025 and held it in 3 quarters. The position peaked at $1.21M in Q1 2026. 13 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Private Advisor Group reported no remaining Columbia Research Enhanced Value ETF position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 42,408 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $1.21M.
  • Private Advisor Group first reported a position in Columbia Research Enhanced Value ETF in Q3 2025 and held it in 3 quarters.
  • Private Advisor Group's Columbia Research Enhanced Value ETF position peaked at $1.21M in Q1 2026.
  • 13 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.